To circumvent the tumor-related oxidative stress, Glutathione (GPx4) and NADPH act synergistically to maintain a cellular redox homeostasis environment via the generation of endogenous antioxidants, represented by the reduced state of glutathione (GSH)
Common side effects like nausea, vomiting, diarrhea and appetite suppression can persuade folks to stop therapy altogether, and many GLP-1 benefits fade when treatment stops
These include: Subcutaneous injections , like Wegovy and Ozempic Oral tablets, like Rybelsus Subcutaneous semaglutide Both Wegovy and Ozempic are injected subcutaneously on a weekly basis , under the skin of the thigh, abdomen, or upper arm
The STEP 1 trial published results in the New England Journal of Medicine in February 2021, showing 14.9% weight loss at 68 weeks (Wilding et al., NEJM 2021)
Studies have shown that patients can lose up to 20% of their body weight with GLP-1 agonists
However, as with any medication, there is the potential for side effects